{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:02:55Z","timestamp":1772017375416,"version":"3.50.1"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>Objectives: The epidermal growth factor receptor (EGFR) is a clinically relevant membrane receptor that is frequently overexpressed or dysregulated in multiple types of cancer, making it an important target for antibody-based strategies. Nanobodies, derived from camelid heavy-chain antibodies, possess favorable properties such as small size, high stability, and strong antigen-binding capacity. This study aimed to generate EGFR-specific nanobodies and to systematically characterize their binding properties and initial functional activity. Methodology: Bactrian camels were immunized with a whole-cell antigen prepared from 293F cells transiently transfected to express full-length human EGFR. A high-diversity phage display nanobody library was constructed from peripheral blood lymphocytes. After two rounds of biopanning against EGFR, positive clones were screened and selected. The identified nanobodies were recombinantly expressed in Escherichia coli and purified. Binding specificity, epitope relationships, and kinetic parameters were evaluated using high-performance liquid chromatography (HPLC), bio-layer interferometry (Octet), and flow cytometry. The effect of selected nanobodies on EGF-induced cell proliferation was evaluated using a CCK-8 assay. Results: Two EGFR-specific nanobodies, Nb2H4 and Nb2B6, were successfully isolated. Both nanobodies exhibited specific binding to EGFR and recognized distinct, non-competing epitopes. Kinetic analyses revealed favorable binding affinities, and flow cytometry confirmed their ability to recognize EGFR in its native cellular context. In addition, Nb2H4 significantly suppressed EGF-induced proliferation in an EGFR-overexpression cell model, indicating preliminary functional activity. Conclusions: This study reports on the successful generation and in vitro characterization of EGFR-targeting nanobodies based on the extracellular domain of EGFR. The identified nanobodies provide useful molecular tools for epitope mapping, structural studies, and the further exploration of EGFR-directed antibody engineering strategies.<\/jats:p>","DOI":"10.3390\/antib15020019","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:58:18Z","timestamp":1771952298000},"page":"19","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Camelid-Derived Nanobodies Targeting Human Epidermal Growth Factor Receptor: Screening, Expression, and Functional Validation"],"prefix":"10.3390","volume":"15","author":[{"given":"Yunfeng","family":"Liu","sequence":"first","affiliation":[{"name":"College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiting","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongna","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjun","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaiying","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchuan","family":"Wen","sequence":"additional","affiliation":[{"name":"College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Kong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"},{"name":"The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev-biochem-060614-034402","article-title":"A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor","volume":"84","author":"Kovacs","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","article-title":"The ErbB\/HER family of protein-tyrosine kinases and cancer","volume":"79","author":"Roskoski","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.str.2013.05.008","article-title":"Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies\/VHH Domains","volume":"21","author":"Schmitz","year":"2013","journal-title":"Structure"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wee, P., and Wang, Z.X. (2017). Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. Cancers, 9.","DOI":"10.3390\/cancers9050052"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7150\/thno.10084","article-title":"Small Sized EGFR1 and HER2 Specific Bifunctional Antibody for Targeted Cancer Therapy","volume":"5","author":"Ding","year":"2015","journal-title":"Theranostics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The Therapeutic Potential of Nanobodies","volume":"34","author":"Jovcevska","year":"2020","journal-title":"Biodrugs"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3892\/ol.2021.12773","article-title":"Triple-negative breast cancer: A run-through of features, classification and current therapies","volume":"22","author":"Manjunath","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Peterson, J.L., and Ceresa, B.P. (2021). Epidermal Growth Factor Receptor Expression in the Corneal Epithelium. Cells, 10.","DOI":"10.3390\/cells10092409"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.11.008","article-title":"Functional selectivity of EGF family peptide growth factors: Implications for cancer","volume":"122","author":"Wilson","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/cbdd.12871","article-title":"99mTc-anti-epidermal growth factor receptor nanobody for tumor imaging","volume":"89","author":"Piramoon","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zubair, T., and Bandyopadhyay, D. (2023). Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032651"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1007\/s11033-013-2790-1","article-title":"Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody","volume":"40","author":"Omidfar","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jbc.2025.110374","article-title":"Nanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations","volume":"301","author":"Watson","year":"2025","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/febs.15515","article-title":"A guide to: Generation and design of nanobodies","volume":"288","author":"Muyldermans","year":"2021","journal-title":"Febs J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Nagano, K., and Tsutsumi, Y. (2021). Phage Display Technology as a Powerful Platform for Antibody Drug Discovery. Viruses, 13.","DOI":"10.3390\/v13020178"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.ymthe.2025.07.004","article-title":"Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+T cell and evading IL-18BP in preclinical models","volume":"33","author":"Nan","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100865","DOI":"10.1016\/j.mcpro.2024.100865","article-title":"Nanobodies: From High-Throughput Identification to Therapeutic Development","volume":"23","author":"Fridy","year":"2024","journal-title":"Mol. Cell. Proteom."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12985-025-02781-z","article-title":"A phage-displayed nanobody-based competitive immunoassay for the detection of African swine fever virus antibodies","volume":"22","author":"Chen","year":"2025","journal-title":"Virol. J."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Arbabi-Ghahroudi, M. (2017). Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01589"},{"key":"ref_22","first-page":"18","article-title":"Nanobody-based CAR-T cells for cancer immunotherapy","volume":"10","author":"Kozani","year":"2022","journal-title":"Biomark. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2310\/7290.2011.00025","article-title":"Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-infrared Fluorescent Anti-Epidermal Growth Factor Receptor Nanobody","volume":"11","author":"Oliveira","year":"2012","journal-title":"Mol. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e0119722","DOI":"10.1128\/jcm.01197-22","article-title":"Identification and Characterization of Nanobodies from a Phage Display Library and Their Application in an Immunoassay for the Sensitive Detection of African Swine Fever Virus","volume":"61","author":"Zhao","year":"2023","journal-title":"J. Clin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00430-009-0116-7","article-title":"Single domain antibodies: Promising experimental and therapeutic tools in infection and immunity","volume":"198","author":"Wesolowski","year":"2009","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tibtech.2014.03.001","article-title":"Nanobody-based products as research and diagnostic tools","volume":"32","author":"Muyldermans","year":"2014","journal-title":"Trends Biotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/IJN.S387160","article-title":"A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)","volume":"18","author":"Lu","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yang, E.Y., and Shah, K. (2020). Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01182"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12951-024-02900-y","article-title":"Discovery of nanobodies: A comprehensive review of their applications and potential over the past five years","volume":"22","author":"Alexander","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/1061186X.2020.1853756","article-title":"EGFR and anti-EGFR nanobodies: Review and update","volume":"29","author":"Sharifi","year":"2021","journal-title":"J. Drug Target."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Narbona, J., Hern\u00e1ndez-Baraza, L., Gordo, R.G., Sanz, L., and Lacadena, J. (2023). Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment. Biomolecules, 13.","DOI":"10.3390\/biom13071042"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"113562","DOI":"10.1016\/j.jconrel.2025.02.058","article-title":"Nanobody-based drug delivery systems for cancer therapy","volume":"381","author":"Liu","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12951-025-03169-5","article-title":"Unveiling the new chapter in nanobody engineering: Advances in traditional construction and AI-driven optimization","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"30297","DOI":"10.1021\/acsami.7b05654","article-title":"Quantum-Dot-Based Theranostic Micelles Conjugated with an Anti-EGFR Nanobody for Triple-Negative Breast Cancer Therapy","volume":"9","author":"Wang","year":"2017","journal-title":"Acs Appl. Mater. Interfaces"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.lfs.2024.122593","article-title":"Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies","volume":"345","author":"Tripathy","year":"2024","journal-title":"Life Sci."}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/15\/2\/19\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:59:58Z","timestamp":1772013598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/15\/2\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["antib15020019"],"URL":"https:\/\/doi.org\/10.3390\/antib15020019","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}